The aim of this study was to determine the effects of glutathione-S-transferase-fused recombinant biglycan (GST-BGN) on craniofacial bone regeneration. We recently demonstrated a positive effect of tissue-derived BGN on bone morphogenetic protein 2 (BMP-2) function, which is exerted likely via the BGN core protein. Here, we investigated the effects of GST-BGN lacking any posttranslational modifications on BMP-2 function in vitro and in vivo. In the C2C12 cell culture system, BMP-2-induced Smad 1/5/8 phosphorylation and alkaline phosphatase activity were both enhanced by the addition of GST-BGN. For the in vivo effect, we employed a Sprague-Dawley rat mandible defect model utilizing 1 µg (optimal) or 0.1 µg (suboptimal) of BMP-2 combined with 0, 2, 4, or 8 µg of GST-BGN. At 2 weeks post-surgery, newly formed bone was evaluated by microcomputed tomography and histologic analyses. The results revealed that the greatest amounts of bone within the defect were formed in the groups of suboptimal BMP-2 combined with 4 or 8 µg of GST-BGN. Also, bone was well organized versus that formed by the optimal dose of BMP. These results indicate that recombinant BGN is an efficient substrate to promote low-dose BMP-induced osteogenesis.
b one defects of congenital and acquired origins are a major health concern to our society, directly affecting the quality and length of life. To regenerate bone, an approach of tissue engineering has been developed consisting of a biocompatible scaffold, osteogenic growth factors such as bone morphogenetic proteins (BMPs), and stem cells. Yet, the clinical use of BMPs faces challenges such as high cost because of the high quantities of BMP required, the difficulties to retain BMP in situ, and a robust post-operative inflammatory response (Selvig et al., 2002; Smucker et al., 2006; Dickerman et al., 2007) .
Biglycan (BGN) , a member of class I molecules in the small leucine-rich proteoglycan family, is one of the major noncollagenous proteins in mineralized tissues (Fisher et al., 1983) . It may function as nucleator for mineral deposition in an in vitro system (Boskey et al., 1997) and/or modulator of osteoblast and chondroblast activities (Bianco et al., 1990) . It also has been shown that BGN is a positive modulator of BMP function and promotes osteoblast differentiation and mineralization (Chen et al., 2004; Parisuthiman et al., 2005) . More recently, using tissue-derived BGN, we demonstrated that this function is likely exerted through the core protein and that the glycosaminoglycan (GAG) rather functions as a suppressor (Miguez et al., 2011) .
Thus, to explore the potential utility of recombinant BGN for BMP-2-induced osteogenesis, we investigated the effect of glutathione-S-transferase-fused BGN (GST-BGN) devoid of the posttranslational modifications including GAGs and N-glycosylation. Our study characterizes the effects of GST-BGN on BMP signaling and functions by the C2C12 cell assay system and then tests the effect of GST-BGN on BMP-2-induced early osteogenesis in a rat mandible defect model. The hypothesis tested was that GST-BGN is a potent BMP-2 function promoter in vitro and in vivo, leading to predictable bone regeneration.
MAtErIAls & MEtHODs
cell culture C2C12 cells were cultured as previously described (Mochida et al., 2006) . Briefly, cells were grown in DMEM (Invitrogen, Carlsbad, CA, USA) with high glucose (4.5 g/L) containing 15% FBS (Invitrogen) and supplemented with 100 U/mL of penicillin G sodium and 100 µg/mL of streptomycin sulfate.
Western blot (WB) with anti-GST antibody (Sigma-Aldrich, St Louis, MO, USA). The effect of GST-BGN on rBMP-2 function (R&D, Minneapolis, MN) was confirmed by alkaline phosphatase (ALP) activity as described elsewhere (Kaku et al., 2007) . Briefly, after 4 days of culture, cell/matrix was lysed with Tris buffer saline containing 0.1% Triton X. ALP activity was measured with ALP yellow (pNPP; p-nitrophenylphosphate) Liquid Substrate System for ELISA (Sigma, St. Louis, MO, USA) according to the manufacturer's protocol. The pNP production was measured by absorbance at 405 nm via a 96-well plate reader. The protein concentration was determined by a DC Protein Assay kit (Bio-Rad, Hercules, CA, USA) and ALP activity calculated as mol of pNP/min/total protein. A one-way analysis of variance was conducted for the variable "treatment" at 95% confidence interval (n = 3). The dose effect of GST-BGN on BMP-2 signaling was evaluated by adding 2, 4, or 8 µg of GST-BGN (based on previous pilot experiments showing no effect of BGN at higher concentrations than 8 µg) combined with 150 ng per 2 mL of BMP-2 to C2C12 cells, followed by the measurement of phosphorylation of Smad 1/5/8. Both experiments were done at least in triplicates. smad 1/5/8, β-catenin, and ErK 1/2 Phosphorylation The effects of GST-BGN on Smad and non-Smad BMP-2 signaling pathways were assessed by the phosphorylation of Smad1/5/8, β-catenin, and ERK 1/2 in C2C12 cells. Briefly, cells were treated with 4 µg of GST-BGN and 150 ng of BMP-2 for 1 hr and extracted with RIPA buffer. The extracts were then applied to 4% to 12% SDS-PAGE followed by WB analyses with anti-phospho (p)-Smad 1/5/8, anti-p-β-catenin antibody, or anti-p-ERK 1/2 (Cell Signaling, Danvers, MA, USA). Levels were normalized to β-actin and β-catenin (cell signaling).
Animal surgery
The surgical procedures were performed as previously described (Zellin and Linde, 1997; Miguez et al., 2011) . Briefly, 5-mm critical-sized defects were generated in mandibles of Sprague-Dawley male rats via a trephine bur. A collagen scaffold loaded with or without proteins was placed within the defect, and bone regeneration was evaluated at 2 wk postsurgery. Animal experiments were approved by the Institutional Animal Care and Use Committee (ID 09-237.0) at the University of North Carolina at Chapel Hill and conform to the ARRIVE guidelines. According to Arosarena and Collins (2005) , 0.1 µg of BMP-2 is considered a "suboptimal" dose of BMP in this model because defects exhibit minimal osteogenesis, whereas 1 µg is an "optimal" dose to promote accelerated and increased bone regeneration of the mandible. Thus, the suboptimal dose of BMP (subBMP) was used to evaluate the effect of GST-BGN on BMP-induced bone formation. The optimal dose of BMP (optBMP) was used for comparison of the amount and organic matrix quality of bone formed to those of subBMP with and without BGN. Control groups included (1) unfilled defect, (2) collagen scaffold alone (Nitta Gelatin Inc, Osaka, Japan), (3) collagen scaffold filled with 4 µg of GST-BGN, and (4) collagen scaffold filled with 4 µg of GST protein alone (i.e., a total of 4 control groups without addition of subBMP). Treatment groups received the scaffold loaded with (5) subBMP alone or combined with (6) 2 µg of GST-BGN, (7) 4 µg of GST-BGN, or (8) 8 µg of GST-BGN and (9) optBMP (i.e., a total of 5 treatment groups). Rats were euthanized as described (Miguez et al., 2011) . Three animals per group were implanted for 2 wk, as the optimal dose of BMP-2 has been shown to promote closure of such mandible defect around this time point (Zellin and Linde, 1997) .
Microcomputed tomography
The mandibles were fixed in 10% formalin and subjected to microcomputed tomography (µCT) analysis via the Scanco Medical µCT (Skyscan, Belgium) as previously described (Miguez et al., 2011) . Bone volume (BV) was determined as BV/total area of the newly formed bone (NFB).
Histologic Analyses
Mandibles were demineralized with 0.5 M EDTA, pH 7.4, for 8 wk, dehydrated, and embedded in paraffin. Sections (6 µm) obtained from the mid-cross section of the mandible defects were stained by Masson's trichrome for histomorphometry or by picrosirius red (PSR) to evaluate collagen organization and maturation (Junqueira et al., 1979) . Osteoclastic activity was analyzed by tartrate-resistant acid phosphatase (TRAP) (Yan et al., 2007) .
rEsults
Effect of Gst-bGn on bMP-2 signaling and Function In Vitro Figure 1A shows SDS-PAGE stained with CBB for the newly generated GST-BGN and GST, revealing the single bands at the expected migration positions at ~70 kDa (45 kDa BGN core + ~26 kDa GST) and ~26 kDa, respectively. WB analysis confirmed that both were immunopositive against anti-GST antibody (not shown). The statistically significant positive effect of GST-BGN on BMP-2-induced ALP activity was observed (lane 6) compared to BMP-2 alone (lane 4) or BMP-2 + GST (lane 5) ( Figure 1B) , which is consistent with a previous report (Mochida et al., 2006) . The Smad 1/5/8 phosphorylation ( Figure 1C ) was induced with BMP-2 (lanes 1, 2) and enhanced with the addition of 2 µg of GST-BGN (lane 3). Phosphorylation was further increased with 4 µg of GST-BGN (lane 4) and stayed at a similar level with 8 µg (lane 5). Figure 1D shows the comparison of Smad and non-Smad signaling in C2C12 cells induced by BMP-2 with and without 4 µg of GST-BGN. Smad 1/5/8 phosphorylation was enhanced by GST-BGN in BMP-2-treated C2C12 cells (upper panel); β-catenin phosphorylation did not change with BMP-2 in the presence or absence of GST-BGN (middle panel) when normalized to total β-catenin. ERK 1/2 phosphorylation was reduced with BMP-2 (lane 2), and the addition of GST-BGN (lane 3) had no apparent effect. In all these in vitro experiments, GST-BGN never exerted any effect by itself at any dose tested, and this was observed in repeated experiments with the same GST-BGN or with different batches of this bacteria-generated protein.
tomographic bV of the nFb in the rat Mandibles . The BV values of control groupsthat is, unfilled, scaffold alone, scaffold + GST-BGN, scaffold + GST (not shown)were not statistically significantly different from that of subBMP (lane 1). Compared with these groups, the amounts of NFB were significantly higher in the optBMP group (lane 2). However, the bone induced by optBMP appeared to be mainly ectopic (see its 2-dimensional image in the middle panel), and less than 80% of the defect area was filled with NFB (defect area identified by upper and lower edges of native bone). Addition of 2 µg of GST-BGN to subBMP-2 (lane 3) did not significantly enhance bone formation compared to that of subBMP-2 alone. However, when subBMP was combined with 4 or 8 µg of GST-BGN, a significant increase in bone formation was observed (lanes 4 and 5, respectively), and the means were similar to optBMP (Wilcoxon rank sum, p > .05).
BV was calculated by the µCT software CTan Analyzer (Skyscan, Kontich, Belgium).
Histologic Evaluation
In control groups, there was minimal NFB at the edge of the defect; thus, not all the histologic images are shown. In Figure 2 , for ease of identification, the edge of the NFB is delineated by a dotted yellow line and the native bone by a solid line. The subBMP group showed a small amount of NFB ( Figure 2B ) compared to the scaffold-only group (Figure 2A) , while the optBMP group showed a much greater amount of NFB ( Figure 2C ). Figure 2D , E, and F show the images obtained from the subBMP groups combined with 2, 4, or 8 µg of GST-BGN, respectively. While NFB/total area percentage did not change with the addition of 2 µg of GST-BGN to subBMP (15.5 ± 2) ( Figure 2D ) compared to that of subBMP alone (8.3 ± 4.2), it increased with 4 µg ( Figure 2E ) and 8 µg of GST-BGN ( Figure 2F ).
PSR staining shown in Figure 3A (4×) and B (40×) demonstrates the collagen matrices of the NFB in the subBMP group are well organized and mature as indicated by the intense red staining of the collagen fibers. The NFB of the optBMP group showed light yellow to red color with patches of green color, indicating that the collagen matrix is less mature and less organized (Figure 3C); upon higher magnification ( Figure 3D) , the coloration was more faint possibly, indicating a thinner collagen matrix. The subBMP + 4 µg and subBMP + 8 µg ( Figure 3E ) groups revealed more red, dense, and thick collagen fibers than those of optBMP alone ( Figure 3C ), as represented by stronger red signaling, although there was some green and yellow scattered patches (Dayan et al., 1989) . Thus, the use of GST-BGN did not compromise the collagen matrix organization/quality as the optBMP group did. TRAP-positive staining was observed only in the optBMP group ( Figure 4A ). In these sections, the TRAP-positive cells were found mostly at the surface of the NFB (Figure 4A) . Figure  4B shows a representative image of subBMP + 4 µg GST-BGN showing no TRAP-positive cells. Quantification is shown in Figure 4C .
DIscussIOn
Recently, we reported that the positive effect of tissue-derived BGN on BMP-2 function was likely exerted through its core protein (Miguez et al., 2011) . In the current study, we tested the utility of recombinant GST-BGN devoid of posttranslational modifications, including GAGs and N-glycosylation (Neame et al., 1989) . In the cell culture system, the positive effect was observed as previously reported (Mochida et al., 2006) . In the current study, the dose effect was examined and seen up to 4 µg of GST-BGN for 150 ng of BMP-2. The effect stayed at the same level with 8 µg of GST-BGN. Saturation of the ratio of GST-BGN to BMP and/or to its receptors may have limited further effect of GST-BGN on BMP function. Also, it is possible that while GST alone did not affect BMP function ( Figure 1B with high doses of GST-BGN, it potentially limits the BGN effect by interfering with the interaction between BMP-2 and its receptors.
Under the conditions used, positive effects were consistently seen for the Smad 1/5/8 pathway but were not observed for other signaling pathways, such as β-catenin and ERK 1/2, by the addition of BMP-2 or BMP-2 + GST-BGN. The reports on the effect of BMP on these signaling pathways are not consistent. Some studies showed that BMP-2 activates Wnt/β-catenin in C2C12, C3H10T1/2, and MC3T3-E1 cells (Rawadi et al., 2003; Zhang et al., 2009) , while others reported the lack of such effect (Nakashima et al., 2005) . In a recent bone fracture-healing model, the callus of BGN-deficient mice reduced gene expression levels of Wnt-induced secreted protein 1, indicating a role of BGN in Wnt signaling (Berendsen et al., 2011) . The discrepancy between the current study and those reports could be due to the assay conditions, such as timing (1-hr incubation in this study), passage effect, and culture conditions, among others. There are also conflicting reports for the effect of BMP-2 on ERK signaling. Gallea et al. (2001) showed an increase of ERK phosphorylation with BMP-2 starting only at 2 hours' posttreatment in C2C12 cells, while Ghayor et al. (2009) reported a decrease in ERK signaling with BMP-2 treatment in C2C12 cells. These are likely due to the differences in the concentrations of BMP-2 and the timing of the assay. Kinetic studies of BMP-2 and BMP-2 + BGN downstream signaling pathways are warranted to identify the mechanisms by which BGN positively modulates the BMP-2 induced osteogenesis.
In the in vivo study, the NFB volume in the subBMP + 4 µg and subBMP + 8 µg groups was significantly greater than those of control groups and similar to that of optBMP (Figure 2 , lower panel). The optBMP group, however, showed significant amounts of ectopic bone formation with limited amounts of bone bridging the defect. With excessive amounts of BMP-2, it could have led to extravasation of BMP to the surrounding tissues. Possibly, a greater amount of collagen per scaffold may help retain such large amounts of BMP-2. In addition, edema has been associated with large quantities of BMP-2 due to exacerbated inflammatory response (Shields et al., 2006; Garrett et al., 2010) , which could contribute to extravasation of BMP to the surrounding connective tissues. Nonetheless, GST-BGN in combination with subBMP may provide a more predictable means of bone regeneration than optBMP, as the NFB was well confined to the defect boundaries. BGN has been shown to bind to collagen (Schonherr et al., 1995) and BMPs (Mochida et al., 2006) . BGN may sequester BMP-2 to the extracellular matrix and thus both increase its potency and reduce negative effects such as edema.
Osteoclasts were identified only in the optBMP group. As reported, BMP-2 causes a dose-and time-dependent increase in bone resorption pits excavated by osteoclasts and increases key enzymes for the degradation of bone matrices (Kaneko et al., 2000) , as supported by the pattern of PSR staining ( Figure 3C and D). When collagen is resorbed and rapidly laid down, the formation of well-aligned mature collagen fibrils could be compromised. In summary, this study accepted the hypothesis proposed and demonstrated the following: First, recombinant BGN devoid of posttranslational modifications specifically and predictably enhances BMP-2 function in vitro and in vivo; second, the bone formed by a low dose of BMP-2 combined with GST-BGN was well organized and mature when compared with that formed by a low or high dose of BMP-2 alone at 2 wk post-surgery; last, Smad pathway is consistently activated by BMP-2 and BGNassisted BMP-2 osteogenesis in vitro. The data suggest that by utilizing a BMP-2 functional effector such as recombinant BGN, smaller quantities of BMP-2 could be used to possibly minimize adverse side effects, such as ectopic bone formation and robust inflammation (Shields et al., 2006; Lee et al., 2011; Zara et al., 2011) , and effectively regenerate craniofacial bone.
